Rachel E. Sutton

5.8k total citations · 3 hit papers
20 papers, 1.6k citations indexed

About

Rachel E. Sutton is a scholar working on Infectious Diseases, Molecular Biology and Ecology, Evolution, Behavior and Systematics. According to data from OpenAlex, Rachel E. Sutton has authored 20 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 4 papers in Molecular Biology and 4 papers in Ecology, Evolution, Behavior and Systematics. Recurrent topics in Rachel E. Sutton's work include Viral Infections and Vectors (8 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Viral Infections and Outbreaks Research (5 papers). Rachel E. Sutton is often cited by papers focused on Viral Infections and Vectors (8 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Viral Infections and Outbreaks Research (5 papers). Rachel E. Sutton collaborates with scholars based in United States, United Kingdom and Germany. Rachel E. Sutton's co-authors include James E. Crowe, Robert H. Carnahan, Pavlo Gilchuk, Seth J. Zost, Rachel S. Nargi, Naveenchandra Suryadevara, Elad Binshtein, Elspeth Payne, Koralia Paschalaki and Francesco Ferraro and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Blood.

In The Last Decade

Rachel E. Sutton

18 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition

2020 568 citations Allison J. Greaney, Tyler N. Starr et al. Cell Host & Microbe profile →
Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein

2021 215 citations Naveenchandra Suryadevara, Swathi Shrihari et al. Cell profile →
Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection

2021 183 citations Emma S. Winkler, Pavlo Gilchuk et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rachel E. Sutton United States	11	997	422	218	211	185	20	1.6k
Kapil Saxena United States	17	291 0.3×	200 0.5×	125 0.6×	92 0.4×	231 1.2×	39	1.2k
Marc‐André Langlois Canada	22	1.1k 1.1×	838 2.0×	394 1.8×	100 0.5×	87 0.5×	76	2.2k
Cyril Planchais France	18	707 0.7×	362 0.9×	432 2.0×	215 1.0×	39 0.2×	43	1.4k
Olga L. Rojas Canada	18	338 0.3×	306 0.7×	739 3.4×	90 0.4×	48 0.3×	36	1.5k
Etsuko Yasuda Netherlands	13	458 0.5×	249 0.6×	380 1.7×	153 0.7×	46 0.2×	28	1.4k
Jon Askaa Denmark	22	355 0.4×	425 1.0×	263 1.2×	55 0.3×	41 0.2×	48	1.5k
Lisa K. Blum United States	16	157 0.2×	170 0.4×	352 1.6×	159 0.8×	53 0.3×	23	993
Steven Rockman Australia	26	288 0.3×	552 1.3×	519 2.4×	146 0.7×	104 0.6×	64	1.6k
Shuai Yuan China	17	367 0.4×	352 0.8×	97 0.4×	46 0.2×	25 0.1×	47	975
Carla Forte United States	10	184 0.2×	441 1.0×	433 2.0×	330 1.6×	99 0.5×	11	1.5k

Countries citing papers authored by Rachel E. Sutton

Since Specialization

Citations

This map shows the geographic impact of Rachel E. Sutton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rachel E. Sutton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rachel E. Sutton more than expected).

Fields of papers citing papers by Rachel E. Sutton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rachel E. Sutton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rachel E. Sutton. The network helps show where Rachel E. Sutton may publish in the future.

Co-authorship network of co-authors of Rachel E. Sutton

This figure shows the co-authorship network connecting the top 25 collaborators of Rachel E. Sutton. A scholar is included among the top collaborators of Rachel E. Sutton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rachel E. Sutton. Rachel E. Sutton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Slough, Megan M., Jacob Berrigan, Troy Hinkley, et al.. (2026). High-resolution in situ structures of hantavirus glycoprotein tetramers. Cell.

2.

Yoder, Sandra, Rachel S. Nargi, Nurgun Kose, et al.. (2023). Development of a Kinetic ELISA and Reactive B Cell Frequency Assay to Detect Respiratory Syncytial Virus Pre-Fusion F Protein-Specific Immune Responses in Infants. Journal of the Pediatric Infectious Diseases Society. 12(5). 298–305. 1 indexed citations

3.

Shiakolas, Andrea R., Kevin J. Kramer, Nicole V. Johnson, et al.. (2022). Efficient discovery of SARS-CoV-2-neutralizing antibodies via B cell receptor sequencing and ligand blocking. Nature Biotechnology. 40(8). 1270–1275. 27 indexed citations

4.

Schoeder, Clara T., Pavlo Gilchuk, Amandeep K. Sangha, et al.. (2022). Epitope-focused immunogen design based on the ebolavirus glycoprotein HR2-MPER region. PLoS Pathogens. 18(5). e1010518–e1010518. 8 indexed citations

5.

Doyle, Michael P., Adam L. Bailey, Nurgun Kose, et al.. (2022). Isolation of a Potently Neutralizing and Protective Human Monoclonal Antibody Targeting Yellow Fever Virus. mBio. 13(3). e0051222–e0051222. 8 indexed citations

6.

Winkler, Emma S., Pavlo Gilchuk, Jinsheng Yu, et al.. (2021). Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection. Cell. 184(7). 1804–1820.e16. 183 indexed citations breakdown →

7.

Zhao, Haiyan, Nurgun Kose, Jonna B. Westover, et al.. (2021). Potent neutralization of Rift Valley fever virus by human monoclonal antibodies through fusion inhibition. Proceedings of the National Academy of Sciences. 118(14). 23 indexed citations

8.

Kuzmina, Natalia A., Adam J. Ronk, Chad E. Mire, et al.. (2021). Broad and potently neutralizing monoclonal antibodies isolated from human survivors of New World hantavirus infection. Cell Reports. 35(5). 109086–109086. 21 indexed citations

9.

Gilchuk, Pavlo, Charles D. Murin, Robert W. Cross, et al.. (2021). Pan-ebolavirus protective therapy by two multifunctional human antibodies. Cell. 184(22). 5593–5607.e18. 23 indexed citations

10.

Suryadevara, Naveenchandra, Swathi Shrihari, Pavlo Gilchuk, et al.. (2021). Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein. Cell. 184(9). 2316–2331.e15. 215 indexed citations breakdown →

11.

Kuzmina, Natalia A., Adam J. Ronk, Chad E. Mire, et al.. (2021). Broad and potently neutralizing monoclonal antibodies isolated from human survivors of New World hantavirus infection. Cell Reports. 36(3). 109453–109453. 3 indexed citations

12.

Johansson, Madeleine, Cecilia Rogmark, Rachel E. Sutton, Viktor Hamrefors, & Artur Fedorowski. (2021). Association of incident fragility fractures in patients hospitalised due to unexplained syncope and orthostatic hypotension. EP Europace. 23(Supplement_3).

13.

Suryadevara, Naveenchandra, Swathi Shrihari, Pavlo Gilchuk, et al.. (2021). Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein. The Journal of Immunology. 206(1_Supplement). 30.13–30.13. 5 indexed citations

14.

Williamson, Lauren E., Theron Gilliland, Pramod Kumar Yadav, et al.. (2020). Human Antibodies Protect against Aerosolized Eastern Equine Encephalitis Virus Infection. Cell. 183(7). 1884–1900.e23. 27 indexed citations

15.

Dong, Jinhui, Robert W. Cross, Michael P. Doyle, et al.. (2020). Potent Henipavirus Neutralization by Antibodies Recognizing Diverse Sites on Hendra and Nipah Virus Receptor Binding Protein. Cell. 183(6). 1536–1550.e17. 41 indexed citations

16.

Greaney, Allison J., Tyler N. Starr, Pavlo Gilchuk, et al.. (2020). Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition. Cell Host & Microbe. 29(1). 44–57.e9. 568 indexed citations breakdown →

17.

Starke, Richard, Koralia Paschalaki, Francesco Ferraro, et al.. (2012). Endothelial Von Willebrand factor regulates angiogenesis. Vascular Pharmacology. 56(5-6). 318–319. 31 indexed citations

18.

Starke, Richard, Koralia Paschalaki, Francesco Ferraro, et al.. (2011). 39 Blood-derived endothelial progenitor cells from Von Willebrand's disease patients demonstrate that Von Willebrand factor regulates angiogenesis. Heart. 97(20). e7.40–e7. 1 indexed citations

19.

Starke, Richard, Francesco Ferraro, Koralia Paschalaki, et al.. (2010). Endothelial von Willebrand factor regulates angiogenesis. Blood. 117(3). 1071–1080. 377 indexed citations

20.

Sutton, Rachel E., et al.. (1996). Essential Guide to Business in the Performing Arts. Medical Entomology and Zoology. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact